HALO
$109.86+2.73%
as of close, Oct 2, 2026
☾ AH $109.86 +2.73%
Halozyme Therapeutics Inc.Stock · Health CareNasdaq Composite 0.02%Russell 3000 0.01%Russell 1000 0.01%US Stock Market 0.01%
Halozyme Therapeutics Inc. returns by year
As of market close, Oct 2, 2026
Halozyme Therapeutics Inc. returns by year (2005–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $67.30 | $109.86 | 0.0% | +63.2% | |
| 2025 | $47.81 | $67.30 | 0.0% | +40.8% | |
| 2024 | $36.96 | $47.81 | 0.0% | +29.4% | |
| 2023 | $56.90 | $36.96 | 0.0% | -35.0% | |
| 2022 | $40.21 | $56.90 | 0.0% | +41.5% | |
| 2021 | $42.71 | $40.21 | 0.0% | -5.9% | |
| 2020 | $17.73 | $42.71 | 0.0% | +140.9% | |
| 2019 | $14.63 | $17.73 | 0.0% | +21.2% | |
| 2018 | $20.26 | $14.63 | 0.0% | -27.8% | |
| 2017 | $9.88 | $20.26 | 0.0% | +105.1% | |
| 2016 | $17.33 | $9.88 | 0.0% | -43.0% | |
| 2015 | $9.65 | $17.33 | 0.0% | +79.6% | |
| 2014 | $14.99 | $9.65 | 0.0% | -35.6% | |
| 2013 | $6.71 | $14.99 | 0.0% | +123.4% | |
| 2012 | $9.51 | $6.71 | 0.0% | -29.4% | |
| 2011 | $7.92 | $9.51 | 0.0% | +20.1% | |
| 2010 | $5.87 | $7.92 | 0.0% | +34.9% | |
| 2009 | $5.60 | $5.87 | 0.0% | +4.8% | |
| 2008 | $7.11 | $5.60 | 0.0% | -21.2% | |
| 2007 | $8.05 | $7.11 | 0.0% | -11.7% | |
| 2006 | $1.82 | $8.05 | 0.0% | +342.3% | |
| 2005 | $2.20 | $1.82 | 0.0% | -17.3% |
- Annualized
- +15.4%
- 2005–2026
- Average year
- +36.0%
- 21 full years
- Best year
- +342.3%
- 2006
- Worst year
- -43.0%
- 2016
- Positive years
- 12/21
- 57% up
Annualized (CAGR)
+15.4%
2005–2026
Average year
+36.0%
21 full years
Best year
+342.3%
2006
Worst year
-43.0%
2016
Positive years
12/21
57% up
Total return by period#
Annual
-300%-200%-100%0%100%200%300%
2005-17%'05
2006+342%
2007-12%'07
2008-21%
2009+4.8%'09
2010+35%
2011+20%'11
2012-29%
2013+123%'13
2014-36%
2015+80%'15
2016-43%
2017+105%'17
2018-28%
2019+21%'19
2020+141%
2021-5.9%'21
2022+42%
2023-35%'23
2024+29%
2025+41%'25
2026+63%
Methodology#
Total returns, dividends reinvested, measured on HALO. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Halozyme Therapeutics Inc.'s average annual return?
- Since 2005, Halozyme Therapeutics Inc. (HALO) has returned about 15.4% a year (the compound annual growth rate) and an average calendar-year return of 36.0%.
- What were Halozyme Therapeutics Inc.'s best and worst years?
- Over 2005–2026, the best year was 2006 (+342.3%) and the worst was 2016 (-43.0%).
- How often is Halozyme Therapeutics Inc. up in a year?
- 12 of the 21 full years since 2005 were positive — about 57% of the time.
More on Halozyme Therapeutics Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100